Article - European Medical Journal

This site is intended for healthcare professionals

Continue

Articles

Hematology
11 Mins
5 Dec 2025

Sponsored Content: Optimal Care of Unfit Patients with FTL3+ AML

This publication is intended for healthcare professionals only and has been commissioned and funded by Astellas Pharma Ltd.
Rheumatology
4 Mins
4 Dec 2025

Twenty-five years of etanercept

Rheumatologist Rieke Alten discusses how treat-to-target care and TNF inhibition with etanercept reshape RA outcomes, with safety…
Neurology
4 Dec 2025

Evidence on VNS in the Modern DRE Treatment Landscape

In this interactive article, explore how drug-resistant epilepsy is linked to decreased quality of life and increased risk of morbidity and..
Oncology
12 Mins
2 Dec 2025

Multi-omics Insights for Biomarkers in NSCLC

Lung cancer remains the most frequently diagnosed malignancy and the leading cause of cancer tumour-related mortality worldwide…
Oncology
7 Mins
2 Dec 2025

Immune Checkpoint Inhibitor-Associated Hydropneumothorax

Immune checkpoint inhibitors (ICI) are monoclonal antibodies capable of reversing cancer-induced immune evasion and promoting tumour death…
Oncology
6 Mins
2 Dec 2025

Recurrent Plexiform Neurofibroma with KRAS and AKT1 Mutations

Plexiform neurofibromas (PNF) are benign, often infiltrative tumours of the peripheral nerve sheath classically linked to neurofibromatosis…
Oncology
4 Mins
2 Dec 2025

Favorable Response of Unresectable Giant Pinealoblastoma

The pineal gland is a small endocrine gland that regulates the circadian rhythm by secreting melatonin. Tumours of the pineal region…
Oncology
12 Mins
2 Dec 2025

CAR-T Cell Immunotherapy for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic modalities such as…
We’ve noticed you’re accessing
from North/South America.